Join the 'Cryptococcal Meningitis' group to help and get support from people like you.
Cryptococcal Meningitis News
Posted 3 Apr 2013 by Drugs.com
WEDNESDAY, April 3 – A drug regimen containing two powerful antifungal medicines – amphotericin B and flucytosine – reduced the risk of dying from cryptococcal meningitis by 40 percent compared to treatment with amphotericin B alone, according to new research. The study also found that those who survived the illness were less likely to be disabled if they received treatment that included flucytosine. "Combination antifungal therapy with amphotericin and flucytosine for HIV-associated cryptococcal meningitis significantly reduces the risk of dying from this disease," said the study's lead author, Dr. Jeremy Day, head of the CNS-HIV Infections Group for the Wellcome Trust Major Overseas Program in Vietnam. "This combination could save 250,000 deaths across Africa and Asia each year. The key to achieving this will be improving access to the antifungal agent flucytosine," said Day, also ... Read more